Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SKYBORNE TECHNOLOGIES USA, LLC via ZIRKELBACH STRATEGIES
2026 · second_quarter · Q2
education on autonomous aerial and ground weapons systems
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via ZIRKELBACH STRATEGIES
2026 · second_quarter · Q2
Source: Senate LDA
| WALGREEN CO |
| 8 |
| 2024–2026 |
| NJOY, LLC | 4 | 2018–2019 |
| SKYBORNE TECHNOLOGIES USA, LLC | 2 | 2026 |
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Overdose Prevention and Patient Safety Act
Client: MAGELLAN HEALTH INC. · Firm: ZIRKELBACH STRATEGIES
health care reform, education on PBMs,opioids. HR6082
Overdose Prevention and Patient Safety Act
Client: MAGELLAN HEALTH INC. · Firm: ZIRKELBACH STRATEGIES
health care reform, education on PBMs,opioids. HR6082
Overdose Prevention and Patient Safety Act
Client: MAGELLAN HEALTH INC. · Firm: ZIRKELBACH STRATEGIES
health care reform, education on PBMs,opioids. HR6082
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
Ensuring Access to Air Ambulance Services Act of 2017
Client: AIR METHODS CORPORATION · Firm: ZIRKELBACH STRATEGIES
H.R. 3378 and S. 2121. air medical transportation issues
HR. 1628 American Healthcare Act - health insurance market issues
HR. 1628 American Healthcare Act - health insurance market issues
HR. 1628 American Healthcare Act - health insurance market issues, medicare advantage
HR. 1628, American health care act - Medicaid issues, Medicare Advantage
HR. 1628, American health care act - Medicaid issues, Medicare Advantage
HR. 1628 American Healthcare Act - health insurance market issues
HR. 1628, American health care act - Medicaid issues, Medicare Advantage
HR. 1628, American health care act - Medicaid issues, Medicare Advantage
retail pharmacy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2026 · second_quarter · Q2
emergency air medical services reimbursement issues
emergency air medical services
emergency air medical services reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2026 · second_quarter · Q2
commercial insurance issues
community directed funding
medicare advantage and medicaid managed care issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKYBORNE TECHNOLOGIES USA, LLC via ZIRKELBACH STRATEGIES
2026 · second_quarter · RR
education on defense technology and Skyborne Technologies, NDAA, defense appropriations
WALGREEN CO. via ZIRKELBACH STRATEGIES
2026 · first_quarter · Q1
retail pharmacy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2026 · first_quarter · Q1
emergency air medical services reimbursement issues
emergency air medical services reimbursement
emergency air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2026 · first_quarter · Q1
community directed funding
commercial insurance issues
medicare advantage and medicaid managed care issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via ZIRKELBACH STRATEGIES
2025 · fourth_quarter · Q4
retail pharmacy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2025 · fourth_quarter · Q4
emergency air medical services
emergency air medical services reimbursement
emergency air medical services reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2025 · fourth_quarter · Q4
commercial insurance issues
medicare advantage and medicaid managed care issues
community directed funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via ZIRKELBACH STRATEGIES
2025 · third_quarter · Q3
retail pharmacy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2025 · third_quarter · Q3
emergency air medical services
emergency air medical services reimbursement
emergency air medical services reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2025 · third_quarter · Q3
commercial insurance issues
medicare advantage and medicaid managed care issues
community directed funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via ZIRKELBACH STRATEGIES
2025 · second_quarter · Q2
retail pharmacy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2025 · second_quarter · Q2
emergency air medical services
emergency air medical services reimbursement
emergency air medical services reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2025 · second_quarter · Q2
commercial insurance issues
medicare advantage and medicaid managed care issues
community directed funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via ZIRKELBACH STRATEGIES
2025 · first_quarter · Q1
retail pharmacy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2025 · first_quarter · Q1
emergency air medical services
emergency air medical services reimbursement
emergency air medical services reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2025 · first_quarter · Q1
commercial insurance issues
medicare advantage and medicaid managed care issues
community directed funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via ZIRKELBACH STRATEGIES
2024 · fourth_quarter · Q4
retail pharmacy issues
Filing targets: HOUSE OF REPRESENTATIVES
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2024 · fourth_quarter · Q4
Access to emergency air medical services and payment issues
access to air medical services and payment issues
education on access to air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2024 · fourth_quarter · Q4
education on skin cancer and skin cancer therapies
education on skin cancer and skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2024 · fourth_quarter · Q4
education on Medicare advantage and medicaid managed care; ACO REACH program
education on health insurance operations
mental and behavioral health programs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via ZIRKELBACH STRATEGIES
2024 · fourth_quarter · RR
pharmacy and retail issues
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2024 · third_quarter · Q3
access to air medical services and payment issues
education on access to air medical services
Access to emergency air medical services and payment issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2024 · third_quarter · Q3
education on skin cancer and skin cancer therapies
education on skin cancer and skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2024 · third_quarter · Q3
education on Medicare advantage and medicaid managed care; ACO REACH program
education on health insurance operations
mental and behavioral health programs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2024 · second_quarter · Q2
education on access to air medical services
access to air medical services and payment issues
Access to emergency air medical services and payment issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2024 · second_quarter · Q2
education on skin cancer and skin cancer therapies
education on skin cancer and skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2024 · second_quarter · Q2
education on Medicare advantage and medicaid managed care; ACO REACH program
mental and behavioral health programs
education on health insurance operations
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2024 · first_quarter · Q1
Access to emergency air medical services and payment issues
education on access to air medical services
access to air medical services and payment issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2024 · first_quarter · Q1
education on skin cancer and skin cancer therapies
education on skin cancer and skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2024 · first_quarter · Q1
education on health insurance operations
mental and behavioral health programs
education on Medicare advantage and medicaid managed care; ACO REACH program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2023 · fourth_quarter · Q4
education on access to air medical services
access to air medical services and payment issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2023 · fourth_quarter · Q4
education on skin cancer and skin cancer therapies
education on skin cancer and skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2023 · fourth_quarter · Q4
education on Medicare advantage and medicaid managed care; ACO REACH program
education on health insurance operations
mental and behavioral health programs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2023 · third_quarter · Q3
access to air medical services and payment issues
education on access to air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2023 · third_quarter · Q3
education on skin cancer and skin cancer therapies
education on skin cancer and skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2023 · third_quarter · Q3
education on health insurance operations
mental and behavioral health programs
education on Medicare advantage and medicaid managed care; ACO REACH program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2023 · second_quarter · Q2
access to air medical services and payment issues
education on access to air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2023 · second_quarter · Q2
education on skin cancer and skin cancer therapies
education on skin cancer and skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2023 · second_quarter · Q2
education on health insurance operations
mental and behavioral health programs
education on Medicare advantage and medicaid managed care; ACO REACH program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2023 · first_quarter · Q1
access to air medical services and payment issues
education on access to air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2023 · first_quarter · Q1
education on skin cancer and skin cancer therapies
education on skin cancer and skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2023 · first_quarter · Q1
education on health insurance operations
mental and behavioral health programs
education on Medicare advantage and medicaid managed care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2022 · fourth_quarter · Q4
emergency air medical services
emergency air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2022 · fourth_quarter · Q4
skin cancer therapies
skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2022 · fourth_quarter · 4T
Pharmaceutical issues related to womens health product access and education on the accelerated approval pathway
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2022 · fourth_quarter · Q4
health insurance issues/covid
medicaid, medicare advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2022 · third_quarter · Q3
emergency air medical services
emergency air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2022 · third_quarter · Q3
skin cancer therapies
skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2022 · third_quarter · Q3
Pharmaceutical issues related to womens health product access and education on the accelerated approval pathway
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2022 · third_quarter · Q3
Pharmaceutical issues related to womens health product access and education on the accelerated approval pathway
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2022 · third_quarter · Q3
health insurance issues/covid
medicaid, medicare advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2022 · second_quarter · Q2
emergency air medical services
emergency air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2022 · second_quarter · Q2
skin cancer therapies
skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2022 · second_quarter · Q2
Pharmaceutical issues related to womens health product access and education on the accelerated approval pathway
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2022 · second_quarter · Q2
medicaid, medicare advantage
health insurance issues/covid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2022 · first_quarter · Q1
emergency air medical services
emergency air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2022 · first_quarter · Q1
skin cancer therapies
skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2022 · first_quarter · Q1
Pharmaceutical issues related to womens health product access and education on the accelerated approval pathway
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2022 · first_quarter · Q1
medicaid, medicare advantage
health insurance issues/covid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EO2 CONCEPTS, INC. via ZIRKELBACH STRATEGIES
2021 · fourth_quarter · Q4
wound care therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2021 · fourth_quarter · Q4
emergency air medical services
emergency air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2021 · fourth_quarter · Q4
skin cancer therapies
skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAGELLAN HEALTH INC. via ZIRKELBACH STRATEGIES
2021 · fourth_quarter · Q4
mental health, behavioral health, Pbm issues
mental and behavioral health, substance abuse issues, Pbm issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2021 · fourth_quarter · Q4
maternal health therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2021 · fourth_quarter · Q4
health insurance issues/covid
medicaid, medicare advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EO2 CONCEPTS, INC. via ZIRKELBACH STRATEGIES
2021 · third_quarter · Q3
wound care therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2021 · third_quarter · Q3
emergency air medical services
emergency air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2021 · third_quarter · Q3
skin cancer therapies
skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAGELLAN HEALTH INC. via ZIRKELBACH STRATEGIES
2021 · third_quarter · Q3
mental and behavioral health, substance abuse issues, Pbm issues
mental health, behavioral health, Pbm issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2021 · third_quarter · Q3
maternal health therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2021 · third_quarter · Q3
health insurance issues/covid
medicaid, medicare advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EO2 CONCEPTS, INC. via ZIRKELBACH STRATEGIES
2021 · second_quarter · Q2
wound care therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2021 · second_quarter · Q2
emergency air medical services
emergency air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2021 · second_quarter · Q2
skin cancer therapies
skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAGELLAN HEALTH INC. via ZIRKELBACH STRATEGIES
2021 · second_quarter · Q2
mental health, behavioral health, Pbm issues
mental and behavioral health, substance abuse issues, Pbm issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2021 · second_quarter · Q2
maternal health therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2021 · second_quarter · Q2
health insurance issues/covid
medicaid, medicare advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2021 · first_quarter · Q1
emergency air medical services
emergency air medical services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EO2 CONCEPTS, INC. via ZIRKELBACH STRATEGIES
2021 · first_quarter · Q1
wound care therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2021 · first_quarter · Q1
skin cancer therapies
skin cancer therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAGELLAN HEALTH INC. via ZIRKELBACH STRATEGIES
2021 · first_quarter · Q1
mental health, behavioral health, Pbm issues
mental and behavioral health, substance abuse issues, Pbm issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2021 · first_quarter · Q1
maternal health therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2021 · first_quarter · Q1
medicaid, medicare advantage
health insurance issues/covid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2020 · fourth_quarter · Q4
Pharmaceutical issues related to womens health product access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EO2 CONCEPTS, INC. via ZIRKELBACH STRATEGIES
2020 · fourth_quarter · Q4
wound care education and wound care reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2020 · fourth_quarter · Q4
emergency air ambulance issues;
emergency air medical education and related medicare reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2020 · fourth_quarter · Q4
education on skin cancer treatments and medicare reimbursement
education on skin cancer treatments and medicare reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAGELLAN HEALTH INC. via ZIRKELBACH STRATEGIES
2020 · fourth_quarter · Q4
medicare advantage, medicare part d and medicaid managed care issues
medicare advantage, medicare part d, medicaid managed care, Pbm issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2020 · fourth_quarter · Q4
health insurance issues
Medicare advantage, part D and Medicaid managed care issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EO2 CONCEPTS, INC. via ZIRKELBACH STRATEGIES
2020 · third_quarter · Q3
wound care education and wound care reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AIR METHODS CORPORATION via ZIRKELBACH STRATEGIES
2020 · third_quarter · Q3
emergency air medical education and related medicare reimbursement issues
emergency air ambulance issues;
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKINCURE ONCOLOGY via ZIRKELBACH STRATEGIES
2020 · third_quarter · Q3
education on skin cancer treatments and medicare reimbursement
education on skin cancer treatments and medicare reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAGELLAN HEALTH INC. via ZIRKELBACH STRATEGIES
2020 · third_quarter · Q3
medicare advantage, medicare part d and medicaid managed care issues
medicare advantage, medicare part d, medicaid managed care, Pbm issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMAG PHARMACEUTICALS via ZIRKELBACH STRATEGIES
2020 · third_quarter · Q3
Pharmaceutical issues related to womens health product access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBLEMHEALTH via ZIRKELBACH STRATEGIES
2020 · third_quarter · Q3
Medicare advantage, part D and Medicaid managed care issues
health insurance issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EO2 CONCEPTS, INC. via ZIRKELBACH STRATEGIES
2020 · second_quarter · Q2
wound care education and wound care reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE